|
BEIJING GEYUANTIANRUN BIO-TECH CO.,LTD.
|
Chondroitin Sulfate
Source: Porcine cartilage tissue
General description
White or almost white powder, slightly salty, odourless, hygroscopic. The water solution is sticky, and would not coagulate when heating. Soluble in water, insoluble in ethanol, acetone and acetic acid.
Application
Ø In the clinical, it always used for the treatment of joint diseases, combined with glucosamine, it could relieve pain, promote cartilage regeneration ,and then fundamentally improve joint problems.
Ø It has a protective effect for corneal collagen fiber, can promote the growth of the matrix in the fiber, enhance permeability, improve blood circulation, accelerate metabolism, promote permeation fluid absorption and elimination of inflammation; Its polyanion has a strong water retention, can improve the moisture metabolism of cornea tissue, has a strong affinity to the cornea, can form a layer of water film on the surface of the cornea, improve the symptoms of dry eye.
Ø It can treat neuropathic headache, trigeminal neuralgia, coronary heart disease, angina pectoris, myocardial ischemia, disease of heart head blood-vessel, joint pain, atherosclerosis and hepatitis syndrome, and it also has the effect of anticoagulant and resisting thrombosis, can also be used as an aid in the treatment of liver function damage and hearing impairment caused by streptomycin .
Ø It can used as health-care products, food additives, can strengthen the body constitution and antibacterial, beauty, anti-aging, and so on. To improve listening and dry skin. In the body can inhibit intestinal absorption of lipid and glucose to help lose weight.
Specification
|
Item
|
Specification
|
Standard
|
|
Apperance
|
White or almost white powder
|
CP2010
|
|
Identification
|
A. Red cuprous oxide precipitate
B. Violet spots
C. Sulfate
|
CP2010
|
|
Loss on drying
|
≤10.0% (105°C,4hours)
|
CP2010
|
|
Residue on Ignition
|
20.0%~30.0%（calculated on the dried basis）
|
CP2010
|
|
Clarity and Color
|
Clarity（5% Water solution）
|
CP2010
|
|
Nitrogen content
|
2.5%~3.5%（calculated on the dried basis）
|
CP2010
|
|
Chloride
|
≤0.6%
|
CP2010
|
|
Microbial Limits：
Pseudomonas aeruginosa
Salmonella
Staphylococcus aureus
|
Absent
|
CP2010
|
|
Absorbance
|
A260 ≤0.28; A280 ≤0.18
|
CP2010
|
|
Assay
|
Amidohexose (with glucosamine (C6H13O5N) which should not be less than 30.0%, calculated on the dried basis.
|
CP2010
|
Storage
Sealed, Dark, at dry place.
|
Send Inquiry
|
Pharma Sources Insight June 2024: Globalization on the Go
